Post-operative radiotherapy in N2 non-small cell lung cancer: A retrospective analysis of 175 patients

Radiotherapy and Oncology

Volumn 96, Issue 1, 2010, Pages 84-88

  Scotti, Vieri ^a   Meattini, Icro ^a   Saieva, Calogero ^b   Agresti, Benedetta ^a   de Luca Cardillo, Carla ^a   Bastiani, Paolo ^c   Livi, Lorenzo ^a   Mangoni, Monica ^a   Cataldo, Vanessa Di ^a   Marrazzo, Livia ^a   Rampini, Andrea ^d   Cipressi, Samantha ^a   Bruni, Alessio ^e   Santini, Paolo ^f   Biti, Giampaolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ISPO   (Italy)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Adjuvant therapy; Non small cell lung cancer (NSCLC); Post operative radiotherapy (PORT); Radiotherapy; Side effects; Thoracic surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; DISTANT METASTASIS; DYSPHAGIA; FEMALE; FOLLOW UP; GENDER; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; RETROSPECTIVE STUDY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; POSTOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; REFERENCE VALUES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77953958601     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.05.010     Document Type: Article

References (32)

1. Feng Q.F., Wang M., Wang L.J., et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys 47 (2000) 925-929
2. Arriagada R., Le Péchoux C., and Pignon J.P. Resected non-small cell lung cancer: need for adjuvant lymph node treatment? From hope to reality. Lung Cancer 42 (2003) S57-64
3. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 315 (1986) 1377-1381
4. Dautzenberg B., Arriagada R., Chammard A.B., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 86 (1999) 265-273
5. Decker R.H., and Wilson L.D. Postoperative radiation therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg 20 (2008) 184-187
6. Mayer R., Smolle-Juettner F.M., Szolar D., et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 112 (1997) 954-959
7. Lally B.E., Zelterman D., Colasanto J.M., Haffty B.G., Detterbeck F.C., and Wilson L.D. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 24 (2006) 2998-3006
8. PORT Meta-analysis Trialists Group. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2005;2:CD002142.
9. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352:257-63.
10. Burdett S., and Stewart L. PORT Meta-analysis Group. Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 47 (2005) 81-83
11. Machtay M., Lee J.H., Shrager J.B., Kaiser L.R., and Glatstein E. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol 19 (2001) 3912-3917
12. Bonner J.A., Tincher S.A., and Fiveash J.B. Balancing the possible effectiveness of postoperative radiotherapy for non-small-cell lung cancer against the possible detriment of radiation-induced toxicity. J Clin Oncol 19 (2001) 3905-3907
13. Van Houtte P., Rocmans P., Smets P., et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 6 (1980) 983-986
14. Stephens R.J., Girling D.J., Bleehen N.M., Moghissi K., Yosef H.M., and Machin D. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Br J Cancer 74 (1996) 632-639
15. Matsuguma H., Nakahara R., Ishikawa Y., et al. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved. Interact Cardiovasc Thorac Surg 7 (2008) 573-577
16. Okawara G., Ung Y.C., Markman B.R., Mackay J.A., and Evans W.K. Lung cancer disease site group of cancer care Ontario's program in evidence-based care. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer 44 (2004) 1-11
17. Karakoyun-Celik O., Yalman D., Bolukbasi Y., Cakan A., Cok G., and Ozkok S. Postoperative radiotherapy in the management of resected non-small-cell lung carcinoma: 10 years' experience in a single institute. Int J Radiat Oncol Biol Phys 76 (2010) 433-439
18. Trodella L., Granone P., Valente S., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 62 (2002) 11-19
19. Bekelman J.E., Rosenzweig K.E., Bach P.B., and Schrag D. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 492-499
20. Sawyer T.E., Bonner J.A., Gould P.M., et al. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 80 (1997) 1399-1408
21. Sawyer T.E., Bonner J.A., Gould P.M., et al. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks. Ann Thorac Surg 64 (1997) 1402-1407
22. Wakelee H.A., Stephenson P., Keller S.M., et al. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Lung Cancer 48 (2005) 389-397
23. Kelsey C.R., Marks L.B., and Wilson L.D. Postoperative radiation therapy for lung cancer: where do we stand?. Oncology (Williston Park) 22 (2008) 301-310
24. Douillard J.Y., Rosell R., De Lena M., Riggi M., Hurteloup P., and Mahe M.A. Adjuvant Navelbine International Trialist Association. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 72 (2008) 695-701
25. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., and Leibel S.A. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 681-685
26. Pitz C.C., Brutel de la Rivière A., van Swieten H.A., Westermann C.J., Lammers J.W., and van den Bosch J.M. Results of surgical treatment of T4 non-small cell lung cancer. Eur J Cardiothorac Surg 24 (2003) 1013-1018
27. Sanborn R.E., and Lally B.E. Adjuvant therapy for non-small cell lung cancer with mediastinal nodal involvement. Thorac Surg Clin 18 (2008) 423-435
28. Ozturk A., Sarihan S., Ercan I., and Karadag M. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy. Am J Clin Oncol 32 (2009) 65-72
29. Keller S.M., Adak S., Wagner H., et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 343 (2000) 1217-1222
30. Bradley J.D., Paulus R., Graham M.V., et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group - RTOG 9705. J Clin Oncol 23 (2005) 3480-3487
31. Feigenberg S.J., Hanlon A.L., Langer C., et al. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. J Thorac Oncol 2 (2007) 287-292
32. Argiris A., Liptay M., LaCombe M., et al. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. Lung Cancer 45 (2004) 243-253